ST Wong is the chief investment officer of Prime Value Asset Management.

What’s the investment question that you always hope to get asked but never do?

Why is making fewer mistakes key to superior investment performance?

There is a lot of focus on the most exciting stocks, but little attention paid to avoiding losers in the market. Avoiding underperformers has a big impact on portfolios: for example, avoiding underperformers in the building materials sector such as Adelaide Brighton and Boral during the last year.

Investment is an odds game – no one gets it right all the time. In fact, the key to investing success is as much about avoiding losers as it is picking winners. Having said that, managing a portfolio is also about balance.

Managing a portfolio too defensively, so it avoids all losers, is counter-productive to superior returns – we try to learn from our losers, move on, and try to avoid repeating the same mistakes.

Conversely, over-celebrating winners and overconfidence can be just as bad. We must be humble and remember many top performing stocks could have been picked just as easily with a pin!

How do you know when you have found a stock that you want to invest in?

I like to hear directly from the management. Candidness and lack of hyperbole are key attributes I look for, as the thing I value most is hearing a balanced view of a business – this means the bad and the good.

My ideal is a business with a valuable franchise which can sustain the business over many years. Typically, I ask simple questions – how likely will the business be here in three-to-five years’ time, and how likely is it to be more valuable than today? I favour simple over complex businesses as it’s very difficult to work out if a business is sustainable.

Knowing why I don’t want to be invested in a stock is just as important. For example, we exited our position in Vocus in 2016 immediately on learning a major shareholder had sold a substantial portion of their holding. Perhaps I acted on the work we had done on Vocus in the past, but it was the right decision.

Do you think that CSL can get to $250?

I think CSL has a very good chance of breaking the $250 mark.

The company’s near-term operating metrics are strong. Notably, CSL’s immunoglobulin business is benefiting from significant US plasma collection footprint investments made by management in the preceding years. CSL’s improved market position comes at a time when product demand is strong and competitors are somewhat constrained to keep pace with supply.

Nevertheless, it’s always useful to get an absolute return perspective. The stock is trading at 34 times 2019-20 earnings, not cheap, and suggests CSL must maintain a strong earnings growth profile to justify its premium P/E ratio. It’s possible the market could underestimate CSL’s earnings potential via further price increases, and the strong pipeline of new specialty products.

What’s your view on the mini-rotation into value?

Rotations happen occasionally as specific ‘style’ or sector valuations ‘blow out’ relative to historical ranges. The rotation we experienced in September is one of those episodes, triggered by an over-extended bond yield, on the downside.

Whether this marks a market leadership change from growth to value as a style is the question.

Do you feel more positive about buying stocks aligned to the domestic economy?

Yes I do. The signs are always tentative in any recovery. But the property market looks to have bottomed, the recent unwinding by APRA and interest rate cuts should be supportive of the economy.Advertisement

Looking ahead into 2020, should there be a pull through in fiscal stimulus, the prospect of activity and wage growth should also be broadly positive.

We’re always looking for new TV shows to stream. What’s caught your eye?

Unabomber, starring Sam Worthington as a FBI profiler working to catch an anonymous bomber who lived like a recluse in the mountains of Montana and built untraceable bombs.

Finally, a recommendation for the readers on a good value quick bite in Melbourne?

Journal Canteen on Flinders Lane. Limited menu but offers home-style Italian food that hits all the right buttons in a great location.

Reporter – Sarah Turner
Sep 25, 2019 – 9.03am

Source: https://www.afr.com/markets/equity-markets/seven-questions-with-st-wong-20190925-p52un4

Related Content

Mitigating small cap risk in a volatile small cap world: Richard Ivers and Mike Younger

8 April 2024

There’s a good reason Prime Value Asset Management’s dynamic small cap duo, portfolio managers Richard Ivers and Mike Younger, have spent much of 2024 on the road, lining up a swag of meets with smaller ASX companies Following the reporting season just gone, the pair have been prepping their Prime Value Emerging Opportunities Fund – […]

CONTINUE READING

Mitigating small cap risk in a volatile small cap world: Richard Ivers and Mike Younger

8 April 2024

Stockhead special guests, Richard Ivers and Mike Younger are a part of the Zenith Small Caps Award-winning Prime Value Asset Management team.    There’s a good reason Prime Value Asset Management’s dynamic small cap duo, Richard Ivers and Mike Younger have spent much of 2024 on the road, lining up a swag of meets with smaller ASX […]

CONTINUE READING

Small caps are ripe for a comeback. Here’s how to pick winners

8 April 2024

Small cap stocks are renowned for rewarding investors with huge returns – a stellar stock can double, quadruple, or rise 10-fold in value over a short time. Software company Pro Medicus has risen more than 200 times from 50¢ per share in 2013 to $105 this week, which means an investment of $5000 has turned into $1 […]

CONTINUE READING
FIND OUT HOW TO INVEST WITH US

We'll get back to you within 24 hours.

CHAT WITH US